[Federal Register Volume 87, Number 208 (Friday, October 28, 2022)]
[Notices]
[Page 65215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23541]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Allergy and Infectious Diseases Special Emphasis Panel, 
which was published in the Federal Register on October 11, 2022, FR Doc 
2022-22017, 87 FR 61342.
    Amendment to change panel name from NIAID Clinical Trial Planning 
Grant (R34 Clinical Trial Not Allowed) to NIAID Clinical Trial Planning 
Grant (R34 Clinical Trial Not Allowed) and Implementation Cooperative 
Agreement (U01 Clinical Trial Required). The meeting is closed to the 
public.

    Dated: October 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-23541 Filed 10-27-22; 8:45 am]
BILLING CODE 4140-01-P